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METHODS
Computer-Assisted Diagnosis in the Noninvasive Evaluation of Patients
With Suspected Coronary Artery Disease
GEORGE A. DIAMOND, MD, HOWARD M. STANILOFF, MD, FACC,
JAMES S. FORRESTER, MD, FACC, BRAD H. POLLOCK, MPH, H. J. C. SWAN, MD, PhD, FACC
Los Angeles, California
A microcomputer program called CADENZA, which
employs Bayes' theorem to analyze and report the results
of various clinical descriptors and noninvasive tests rel-
ative to the diagnosis of coronary artery disease, was
evaluated in 1,097 consecutive patients without previous
myocardial infarction. With this program, each patient
was characterized by a probability for coronary artery
disease, based on Framingham risk factor analysis,
symptom characterization, electrocardiographic stress
testing, cardiokymography, cardiac fluoroscopy, thal-
lium perfusion scintigraphy and technetium equilib-
rium-gated blood pool scintigraphy. A total of 11,808
probability estimates derived from various combinations
of the available observations were analyzed: 2,180 in 170
patients undergoing coronary angiography and 9,628 in
969 patients who completed a 1 year follow-up for cor-
onary events.
The predicted probability of disease correlated lin-
early with observed angiographic prevalence in the 170
patients who subsequently had coronary angiography
(prevalence = [0.001 ± 0.011] + [0.966 ± 0.019] x
CADENZA, an acronym for "computer-assisted diagnosis
and evaluation of coronary artery disease," is a microcom-
puter program that analyzes and reports the results of various
important clinical descriptors and noninvasive tests relative
to the diagnosis of coronary artery disease (1-4). The pro-
gram employs a data base of more than 60,000 patients from
the medical literature to calculate the probability of coronary
artery disease according to Bayes' theorem (1,2). This report
describes our experience with CADENZA in a large cohort
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probability). The difference between probability and
prevalence averaged 3.1 %, and the magnitude of this
correlation was not affected by the type or amount of
data analyzed. The prevalence of multivessel disease in
these patients increased as a monotonic function of dis-
ease probability. Below a probability of 25%, single ves-
sel disease was slightly more common than multivessel
disease. Above a probability of75%, multivessel disease
predominated. In the 969 patients followed up for 1 year
from the date of testing, the incidence of cardiac death
and nonfatal infarction increased as a cubic function of
disease probability (from approximately 0 to 8% per
year for each). Above a probability of 90%, however,
the standard deviation for predicting these events was
wide.
These data indicate that Bayes' theorem in general-
and CADENZA in particular-is an accurate, clinically
applicable means for quantifying the prevalence of an-
giographic coronary artery disease, the risk of multi-
vesseldisease and the incidence of morbid coronary events
in the year after testing.
of patients typical of those referred for noninvasive diag-
nostic testing and assesses its applicability for predicting
the angiographic presence and severity of disease as well
as the subsequent incidence of morbid coronary events.
Methods
Study patients. The study population comprises 1,097 con-
secutive patients (mean age ± standard deviation 56 ± II years)
without previous myocardial infarction or coronary bypass surgery
who were evaluated by noninvasive testing for suspected coronary
artery disease in the Cedars-Sinai Medical Center Cardiac Stress
Laboratories between January I, 1979 and November 15, 1980.
The majority of these patients were referred for testing because of
symptoms or findings that their physicians considered consistent
with possible myocardial ischemia. Asymptomatic patients were
a heterogeneous group, including those referred for physical fitness
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evaluation, arrhythmias, rest electrocardiographic abnormalities or
a previou sly "abnormal" stress test , or any combination thereof.
Baseline characteristics of the study population are summarized in
Table I .
Chest pain classification. All patients completed an explicit
questionnaire concerning the presence of symptoms consistent with
myocardial ischemia at the time of testing and were classified into
one of four groups based on three historic criteria relative to lo-
cation, precipitation and relief of discom fort (2,4,5). Patients were
considered to have typical angina if they complained of substernal
discomfort which was precipitated by physical exert ion and re-
lieved within 10 minutes by rest or nitroglycerin . Patients were
considered to have atypical angina if their discomfort was either
not substernal, not precipitated by exertion or not relieved by rest
or nitroglycerin. Patients were considered to have nonanginal dis-
comfort if more than one of these three defining characteristics
were absent. Any patient who denied discomfort above the level
of the diaphragm was considered to be asymptomatic .
Diagnostic testing. Each patient was evaluated for coronary
risk factors in accordance with the definition s employed in the
Framingham study (6), and underwent a symptom-limited. max-
imal treadmill exercise study according to the Bruce protocol.
Cardiac medications were withheld for at least 12 (and usually 48
to 72) hours before testing . If more than one exercise test was
performed 011 any patient , only the first was employed for data
analysis. Every patient subsequently or simultaneously underwent
at least one additional diagno stic test, including cardiac fluoros-
copy for detection of coronary artery calcification (7), cardioky-
mography (8), thallium perfusion scintigraphy (9) and technet ium-
gated blood pool scintigraphy (10). The details of each of these
procedures , as performed in our laboratory , have been published
previously (2,9, 10). All tests were obtained at the specific request
of the referring physician, as part of his clinical evaluation, and
the findings were transmitted to him by way of the laboratory' s
standard clinical reports.
Table 1. Study Population
Follow-up Angiography
(no = 974) (no. = 170)
no. % no. %
Se.t
Men 683 70 123 72
Women 291 30 47 28
Symptoms
Asymptomatic 278 29 41 24
Nonangmal pain 294 30 36 21
Atypical angina 226 23 43 25
Typical angina 176 18 50 29
Test Procedures
Risk factor analysis 974 100 170 100
ECG stress test 974 100 170 100
Cardiac fluoroscopy 649 67 82 48
Cardiokymography 425 44 93 55
Thallium scintigraphy 710 73 115 68
Technetium scintigraphy 413 42 102 60
ECG =electrocardiogram.
A total of 170 patients (15% of the study population) were
subsequently referred for diagnostic coronary angiography during
the study period. This decision was made by the referring phy-
sician- presumably on the basis of the total clinical evaluation-
with the informed consent of the patient. These patients were
classified from the official catheterization laboratory clinical an-
giographic report according to the number of major coronary ves-
sels with at least 50% diameter narrowing.
Follow-up for coronary events. Patients were telephoned by
a trained interviewer during the month of the first anniversary of
their initial stress test. The follow-up interview consi sted of a 5
minute questionnaire designed to determine if the patient had died
of cardiac (8 events), or noncardiac (5 events) causes, had had a
nonfatal myocardial infarction (7 events) or had undergone cor-
onary artery bypass surgery (47 events) during the year after test-
ing . If such an event was reported , it was then confirmed by
obtaining the appropriate official record (hospital chart or death
certificate, or both) . Over the period of this study, only 3% of
patients were lost to follow-up . Those who underwent coronary
angiography during the follow-up period were analyzed separately,
because the primary physician ' s knowledge of coronary anatomy
might have influenced subsequent outcome.
Probability of coronary artery disease. In addition to the
clinical history and risk factor assessment, each patient underw ent
from 2 to 5 noninvasive diagnostic tests (average 3.3 per patient ),
providing from 4 to 32 different test combinations per patient.
Thus, a total of9,680 test combinations were available for analysis
in the 974 patients with annual follow-up, and 2, 180 conbinations
in the 170 patients referred for coronary angiography. The prob-
ability of having coronary artery disease after testing-conven-
tionally termed the " posterior" coronary artery disease probability
(3)- was calculated for each of these combinations by analysis of
20 specific observations summarized in Table 2. Four of these
observations were binary, nine were compartmentalized into three
to six grades and seven were assessed as continuous variable s.
The probability determinations employed an Apple II (Apple Com-
puter , Cupertino, California) microcomputer and a software pro-
gram called CADENZA (Cardiokinetics, Seattle, Washington) (11).
This program uses previously published empiric data (1-5) which
are analyzed by Bayes' theorem (12). The computational algo-
rithms incorporated in this program are enumerated in the first
three sections of the Appendix. A less formal presentation of
Bayesian probabil ity analysis is summarized in previous reports
from our laboratory (1- 3).
Statistical analysis. Statistical analysis of these data is sum-
marized in the Appendix and will be discussed as the results are
presented. Statistical significance was assessed by use of Jeffreys'
K statistic (13), an estimator of likelihood that was converted into
an " exact" posterior probability (Appendix), denoted by the
Greek letter 1/1. This conversion assumes the null hypothe sis in
question to be represented by a uniform beta distribution (14). The
1/1 statistic is properly interpreted as the maximal informational
probability that the hypothesis complementary to the null hypoth-
esis is true , given the empiric observations . In practical terms, the
1/1 statistic expresses the probabilit y that the experimental hypoth-
esis is true . Its value ranges from 0 , where the hypothesis is certain
to be false, to I, where the hypothesis is certain to be true .
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Table 2. Variables Analyzed by CADENZA
Variable
History
Age (yr)
Sex
Chest discomfort
Systohc BP (mm Hg)
Cholesterol (rng/dl)
Currently smoking
Glucose intolerance
Rest ECG
ECG Stress Test
Duration of exercise (min)
Magnitude of ST depression (mm)
Slope of ST segment
R wave amplitude change (mm)
Fluoroscopy
No. of calcified vessels
Cardiokymography
Rest pattern
Postexercise pattern
Thallium Scintigraphy
Type of defect
Magnitude of defect
Pulmonary uptake
Technetium Scintigraphy
Rest ejection fraction (%)
Peak exercise ejection fraction (%)
Measurement Interval
Continuous
Male, female
AS,NA,AA,TA
Continuous
Continuous
Yes, no
Yes, no
Normal, abnormal
Continuous
<0.5, 0.5, 1.0, 1.5, 2.0, >2.5
Upslopmg, horizontal, downsloping
Contmuous
0, 1,2,3
I, II, III
I, II, III
None, fixed, reversible
Mild, moderate, severe
None, mild/moderate, moderate/severe
Continuous
Contmuous
Conditional Variable
Age, sex
Sex
Age, sex
Sex
Sex
Sex
Sex, rest ECG
Rest ECG
Age
Rest pattern
Type of defect
AA = atypical angina; AS = asymptomatic; BP = blood pressure; ECG = electrocardiogram. I = Inward 'yqohc monon, II = rmd-systohc outward motion. III =
holosystolic outward motion; NA = nonangmal discomfort, TA = typical angina
Results
Probability of coronary artery disease and disease
prevalence. We first evaluated the ability of coronary ar-
tery disease probability to predict the prevalence of anatomic
disease in the 170 patients who were referred subsequently
for angiography. The probability of disease based on age
and sex did not differ significantly from angiographic prev-
alence within each symptom class. This finding is similar
to that reported previously by us (2,5) and by the Coronary
Artery Surgery Study (4), and emphasizes the importance
of the clinical history as a potent diagnostic test. Figure 1
illustrates the probability of disease based on age, sex,
symptom class and Framingham risk factors. In each symp-
tom class, the probability of coronary artery disease was
slightly, but consistently, higher in the 124 patients with
disease than in the 46 patients without disease (l/J=0.878),
indicating that the risk factors developed within the Fra-
mingham study were modest discriminators for coronary
artery disease independent of symptom classification (IS).
All 170 catheterized patients underwent electrocardio-
graphic stress testing. Additionally, 82 patients had cardiac
fluoroscopy, 93 had cardiokymography, 115 had thallium
scintigraphy and 102 had technetium scintigraphy. Table 3
summarizes the probability of disease according to the num-
ber of diseased vessels found at coronary angiography. These
data were assessed in three ways: 1) based on age, sex,
symptom class and risk factors, but prior to diagnostic test-
ing; 2) based on all available data prior to catheterization;
and 3) based on every possible combination of the tests
performed on each patient. In each case, the probability of
Figure I. Probability for angiographic coronary artery disease (CAD),
based on (thus, "posterior" to) age, sex, symptom class and Framingham
risk factors. AA = atypical angina; AS = asymptomatic; NA = non-
anginal discomfort; TA = typical angina.
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Table 3. Coronary Artery Disease Probability and Angiography
No. of Diseased Vessels
0 2 3 1+2+3
Patients (no.) 46 21 46 57 124
Estimates Before Testing
Mean probability 0.291 0595 0.623 0.660 0.635
Standard deviation 0.259 0.342 0.334 0.327 0.332
Estimates Before An§iography
0.745 0.772 0.843 0.800Mean probability' 0.253
Standard deviation 0.322 0.387 0.32\ 0.284 0.315
All Estimates
Test combmanons 500 316 640 724 1680
Mean probability 0.304 0.557 0730 0.746 0.704
Standard deviation 0.321 0377 0.323 0.331 0.322
disease tended to increase in proportion to the number of
diseased vessels, but the standard deviations were large.
Figure 2 (left panel) illustrates the frequency distributions
of all 2,180 raw probability estimates according to the num-
ber of diseased vessels, The mean probability for disease
increased from 30% for the 500 estimates in the normal
group to 56% for the 316 estimates in patients with single
vessel disease (t/J=0.999), and to 75% for the 724 estimates
in patients with triple vessel disease (t/J = 0,999), There was
a great deal of overlap in the distribution of these data,
however, especially between two vessel and three vessel
disease, which were not significantly different from each
other (t/J= 0,018). Thus, 8% (40 of 500) of the probability
estimates in the 46 normal patients were in excess of 90%,
while 9.7% (163 of 1,680) of the probability estimates in
the 124 patients with angiographic disease were under 10%,
These raw distributions are highly asymmetric. For sta-
tistical analysis, therefore, these data are appropriately
modeled by being fit to the beta probability distribution
(Appendix, Beta Frequency Distribution). Figure 2 (right
Figure 2. Posterior probability distribution. Left
panel; Raw distribution of posterior probability based
on age, sex, symptom class, Framingham risk fac-
tors and all combinations of noninvasive test results
(2,180 estimates in 170 patients). There is a trend
toward a greater probability as the number of dis-
eased vessels increases. Right panel; Beta distri-
bution of posterior probability derived from the means
and standard deviations of the data in the left panel.
The fitted distributions correlate closely with the raw
data (average difference = 3.5%). Analogous dis-
tributions based on specific combinations of test re-
suits were similar.
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panel) illustrates the beta distributions for the data in the
left panel of the figure. The difference between the raw
distributions and the corresponding beta distributions av-
eraged only 3.5%. On this basis, the beta distributions were
employed in all subsequent data analysis,
Figure 3 illustrates the relation between probability of
coronary artery disease and the observed prevalence of dis-
ease at angiography, based on the beta distributions defined
by the data in Table 3 and illustrated in Figure 2. The average
difference between the observed prevalence of disease and
that predicted by probability of coronary artery disease was
3.4% for estimates based on age, sex, symptoms and risk
factors (t/J= 0.039). For estimates based on all available tests
before angiography, the difference between observed and
predicted prevalence averaged 3.0% (t/J=0.038), and for
all combinations of test results the difference was 3.1%
(t/J;= 0.013). For each set of data, the slope of the correlation
between probability and prevalence was near unity and the
y intercept was near zero by chi-square minimization (Fig,
3). These correlations indicate that calculated probability of
coronary artery disease accurately reflected the actual an-
giographic disease prevalence, regardless of the amount of
data analyzed.
To determine if the magnitude of the correlation between
probability and prevalence varied as a function of the spe-
cific tests employed, different combinations of tests were
analyzed separately. Figure 4 illustrates the correlation be-
tween probability of coronary artery disease and angio-
graphic prevalence of disease for eight different combina-
tions, including the electrocardiographic stress test alone
and the four two-test combinations that employed this test.
In each case, the previously noted linear relation between
probability and prevalence was maintained, indicating that
the accuracy of a given probability estimate was generally
independent, not only of the amount, but also of the type
of data analyzed.
Probability of coronary artery disease and extent of
disease. Figure 5 illustrates the relation between coronary
artery disease posterior probability and the relative extent
of angiographic disease. These curves were calculated from
the beta distributions for single, double and triple vessel
disease illustrated in Figure 2, and are normalized for total
disease prevalence. Thus, at any posterior probability, the
sum of the three relative prevalences is fixed at 100%. As
in Figure 2, the configuration of the graphs representing
double vessel disease and triple vessel disease was nearly
identical, supporting the practical relevance of the widely
employed term' 'multivessel disease. " Accordingly, Figure
6 expresses the prevalence of single vessel disease and mul-
tivessel disease (the sum of double and triple vessel disease)
as a function of posterior probability. These curves illustrate
that below a probability of 25% (PI), when disease was
present, single vessel disease was slightly more prevalent
than multivessel disease, while above a probability of 75%
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Figure 3. Angiographic prevalence of coronary artery disease (CAD)
(y axis) as a function of posterior probability (x axis), The top panel
employs 170 probability estimates derived from consideration of age, sex,
symptom class and Frammgham fisk factors, The middle panel is for 170
estimates that employ these data plus the results of all tests performed.
The bottom panel is for all 2,180 combinations of data, The white line
represents the mean of each correlation and the black band is I standard
deviation on either side of the mean, In each case, the correlation between
prevalence and probability was closely approximated by a linear function
approaching identity:
Top: y = 0.074 ± 0.010 + (0,932 ± 0.011) x,
Middle: y = 0,001 ± 0,011 + (0.966 ± 0,019) x,
Bottom: y = 0,039 ± 0,011 + (0,917 ± 0,018) x.
When the mean probability and its standard deviation were replaced by
the" exact" posterior probability (see Appendix, The Exact Posterior Prob-
ability), the standard error of the estimate for its correlation with angio-
graphic prevalence decreased by an average of 59%, justifying its use as
a summary statistic,
Figure 4. Correlation between posterior probability and angiographic
prevalence of coronary artery disease (CAD) for various combinations of
tests, The two most extreme combinations are labeled, ECG = electro-
cardiographic stress test; TC = technetium blood pool scintigraphy; TL
= thallium perfusion scintigraphy, The standard deviations for the cor-
relations all overlap each other and, therefore, are not illustrated,
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'Includes 4690 estimates predicted from posterior probabihty to have disease bUI
no event, and 560 surgical estimates predicted from Figure 7 not 10 have an event.
(8900 x 0.527) + (592 - 20 - 12) = 5250 ~rncludes 20 surgical estimates
predicted from Figure 7 to have mfarction tlncludcs 12 surgical estimates predicted
from Figure 7 to have a cardiac death
CAD = coronary artery disease
Figure 6. Prevalence of single vessel and multi vessel disease as a function
of postenor probability. At a probability of 25% (pd, it IS most likely that
disease is not present. In those with disease, however, the prevalence of
single vessel disease just equals that for multivessel disease. At a proba-
bility of 75% (P2), the prevalence of multivessel disease just equals that
for nonmultivessel disease. At a probability of 100% (P3), rnultrvessel
disease accounts for 89% of all disease .
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Table 4. One Year Follow-up for Coronary Events
No. of No. of CAD Standard
Class Patients Estimates Probabiltty Deviation
Observed (patients)
No events 907 0.486 0.403
Bypass surgery 47 0.898 0.251
Myocardial infarction 7 0.874 0.308
Cardiac death 8 0.795 0.333
Observed (estimates)
No events 8900 0.527 0.381
Bypass surgery 592 0.858 0.252
Myocardial infarction 72 0816 0.282
Cardiac death 64 0.746 0.301
Predicted (estimates)
No events 5250* 0.547 0.375
Myocardial infarcnon 9211 0.825 0.276
Cardiac death 76+ 0.763 0.294
then, should be expected to underestimate the rate of morbid
events in a diseased stress test population for two reasons.
First, it is likely that not all of the patients without events
had coronary disease because their probability of coronary
artery disease averaged only 49%; second, the surgically
treated patients, presumably with a higher risk, were ex-
cluded from analysis. In order to better estimate the event
rate for a diseased cohort before surgical referral, the data
were normalized by assuming that the event rate for patients
with coronary artery disease referred to surgery is the same
as for those not so referred at a given level of posterior
probability (Table 4). The total event rate was thereby pre-
dicted to be 3.1 % (1. 7% for infarction and 1.4% for cardiac
death). The relation between posterior probability and nor-
malized annual event rate is illustrated in Figure 8. These
graphs allow the posterior probability to serve as an esti-
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Figure 5. Posterior probability and relative prevalence of single, double
and triple vessel disease. The black bands are the standard deviation of
the mean correlations. Relanve prevalence of single vessel disease de-
creases, while those for double and triple vessel disease increase in parallel
as a function of probability.
(P2), multivessel disease predominated. At a probability of
100% (P3), multivessel disease accounted for 89% of all
angiographic disease. The significance level for these ob-
servations varied as a function of posterior probability.
Nevertheless, these data indicate that disease probability
also acted as a quantitative measure of anatomic severity.
Probability of coronary artery disease and future cor-
onaryevents. Table 4 summarizes the results of probability
analysis in the 969 patients followed up for 1 year after the
date of testing, excluding 5 patients who had a documented
noncardiac death. In 47 patients, follow-up was interrupted
by referral for coronary artery bypass surgery. There were
15 (1.6%) morbid events (7 nonfatal infarctions and 8 car-
diac deaths) in the 922 patients who did not undergo cor-
onary angiography or bypass surgery during the follow-up
period. A total of 9,628 estimates of probability were ana-
lyzed: 8,900 in the 907 patients without morbid events, 592
in the 47 surgical patients and 136 in the 15 patients with
morbid events. Posterior probability was significantly higher
in each of the three event groups compared with the non-
event group (ljJ = 0.999 for all). Figure 7 illustrates the
annual coronary event rate as a function of posterior prob-
ability. The event rates for myocardial infarction and for
cardiac death were similar in magnitude (ljJ = 0.103), and
each increased as a cubic function of probability.
The curves in Figure 7 were derived from only those
patients who were not referred to surgery. This analysis,
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Myocardial Infarction
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the observations are independent of one another. For in-
stance, an individual patient's probability for having cor-
onary artery disease may change from 10 to 50% on the
basis of test results, but the actual prevalence of disease in
a group of patients with a 10% probability should be 10%
and, in a group of patients with a 50% probability, the actual
prevalence should be 50%. Additional testing, then, moves
the individual patient to a different population subset with
a different disease prevalence and a different probability
which represents that prevalence.
Previous reports on CADENZA. This correlation of
posterior probability with angiographic prevalence has been
reported in various ways both by us (2) and by others.
Chaitman et al. (5) demonstrated the relation of a symptom
classification very similar to ours with angiographic prev-
alence of disease in 8,192 patients evaluated as part of the
Coronary Artery Surgery Study (CASS); probability esti-
mates obtained from CADENZA correlated accurately with
their empiric observations (4).
Greenberg et al. (16) evaluated 113 patients similar to
ours by history and electrocardiographic stress testing. They
analyzed these data both by multivariate analysis (17) and
by CADENZA. The difference between probability and
prevalence in these patients averaged 4.1 % for multivariate
analysis and 8.1% for CADENZA. The patient by patient
correlation between the two methods was linear and highly
significant. These findings are all the more impressive be-
cause the design of this study favored the multivariate for-
mat, in that the discriminant coefficients were derived in-
ternally (personal communication).
Dans (personal communication) employed CADENZA
in a retrospective analysis of patients referred for angiog-
raphy at the Johns Hopkins Hospital. Of 43 catheterized
patients with a disease probability of less than 10% (average
2.8%), only 1 (2.3%) had angiographic coronary artery
disease. Patients with a high probability were not analyzed
in this study.
Wong et al. (18) prospectively evaluated 253 patients
similar to those in our study, using history, stress testing,
nuclear scintigraphy and CADENZA. They found that pos-
terior probability was predictive of angiographic prevalence
in the 68 catheterized patients. In addition, they reported
that the probability estimates correlated significantly with
the judgment of experienced cardiologists.
Hlatky et al. (19) also confirmed the accuracy of CA-
DENZA in predicting angiographic disease. They reported
an accuracy of 90% based on age, sex, symptoms, electro-
cardiographic stress testing and thallium scintigraphy in 51
patients. In their study, the computerpredictions were slightly,
but significantly, more accurate than the clinical judgment
of 91 experienced cardiologists (19,20).
Possible limitations in clinical application. A number
of other investigators have verified the underlying applic-
ability of Bayes' theorem for diagnosis of coronary artery
disease (21-28). Yet, despite this impressive body of data,
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Discussion
This study documents the clinical applicability of a mi-
crocomputer program that employs empiric data and Bayes-
ian analysis for the noninvasive diagnosis of coronary artery
disease in three broad areas: for diagnosis, by the correlation
of posterior probability with angiographic prevalence; for
evaluation, by the relation of posterior probability to the
anatomic severity of disease and for prognosis, by the re-
lation of posterior probability to the annual incidence of
morbid coronary events.
Prevalence of disease. The probability for coronary ar-
tery disease correlated almost linearly with the observed
angiographic prevalence of disease, and the magnitude of
this correlation was not dependent on the type and amount
of data analyzed. Thus, a given value of probability based
only on the patient's age, sex, symptom classification and
Framingham risk factors was just as accurate as one based
also on various combinations of noninvasive test procedures.
The first impression given by such a result is that addi-
tional testing is of no value. On reflection, however, it
becomes apparent that posterior probability should always
correlate well with actual disease prevalence whether 1 or
even 10 tests are employed, provided that the sensitivity
and specificity of each test are accurately known and that
.2 .4 .6 .8
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mator of risk for a morbid coronary event in patients with
coronary artery disease over the year following testing.
Figure 7. Relation between coronary events at I year and posterior prob-
ability after excluding patients referred for coronary artery bypass surgery.
The incidence of cardiac death and that of nonfatal myocardial infarction
both increase similarly as a cubic function of probability.
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Table S. Regression Functions for Continuous Variables
Probability Observation
Characteristic (p) (j)
Symptom class p(o+) Age (yr)
R wave amplitude p(TJIO,) mm
Coronary calcification p(TJIO,) Age (yr)
Ejection fraction p(T,IO,) Percent
Exercise time p(T,IO,) Minutes
Regression Function
F(j)
III+e-'UI'+bl+<)
lIae"-b)ll '
III+ e -'al'+bl +<1
aN-j)'
l/ae' -bl'I'
The symbols a, band c are constants and e IS the base to the natural logarithms Other symbols are defined in the Appendix.
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Figure 8. Predicted relation between coronary events at 1 year and pos-
terior probability before surgical referral. The curves are shifted upward
in comparison with Figure 7, reflecting an increase in the predicted event
rate (see text and Table 4).
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estimates, on which the method is based, "travel" well
from laboratory to laboratory (36) despite local differences
in methodology. Thus, posterior probability might be an
appropriate characteristic for antecedently defining subsets
of patients in multicenter trials and epidemiologic studies
where angiographic diagnosis is not feasible (Rozanski A,
Diamond GA, Berman DS, et aI., unpublishedobservations).
Severity of disease. Posterior probability also served as
a predictor of the extent of angiographic disease, because the
prevalence of multivessel disease increased as a monotonic
curvilinear function of probability to a high of 90% when
disease probability was 100%. This result is not unexpected.
It is well known that the sensitivity of noninvasive tests is
highest in patients with more severe disease. Thus, both
multivessel disease and higher grade stenosis have been
probability analysis is sparsely employed as a formal clinical
tool. There are at least two reasons for its limited accep-
tance. First, its recondite nature conflicts with the require-
ment of practicality. The ready availability of microcom-
puters and their growing acceptance by clinicians are,
however, slowly overcoming this objection (24,29-32).
The second impediment to the acceptance of probability
analysis relates to a fundamental theoretical objection. Un-
like conventional clinical judgment, the use of Bayes' theo-
rem rigorously and explicitly assumes that the individual
observations analyzed are all stochastically independent.
Although it is very unlikely that this condition is fulfilled
often, there are at least three indirect lines of evidence to
support the appropriateness of this assumption on a practical
level. First, Bayes' theorem has been shown to be relatively
robust in terms of dependence unless the number of such
variables is large (33). In our study, anywhere from 7 to
20 variables per patient were analyzed (average = 14), but
only a small fraction of these would be expected to be highly
dependent. Charuzi et al. (34), for instance, reported no
significant dependence among several of the major variables
analyzed in this study. Second, as noted earlier, methods
that do not assume independence (multivariate analysis, for
example) result in probabilities similar to those determined
from Bayes' theorem (16). Third, the linear correlation be-
tween probability and prevalence reported in this study is
of itself support for the relative independence of the vari-
ables analyzed. If, for example, the degree of dependence
were major, any correlation that incorporated all available
data should have been significantly less accurate than one
that employed the fewest variables. As shown in Figure 3,
however, the accuracy of these correlations was almost iden-
tical. In fact, the observed probability and standard deviation
for the normal groups and patients with disease (Table 3)
were very similar to those predicted on the ideal assumption
of total independence (the predicted mean for normal sub-
jects was 33%; the predicted mean for patients with disease
was 67% and the standard deviation for each was 27%)
(35).
We believe, therefore, that the broad clinical experience
reported here and from other institutions adequately supports
the accuracy and practical utility of empiric Bayesian anal-
ysis. These observations further imply that the published
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shown to be more frequently associated with abnormal test
responses than are lesser degrees of disease severity (22,34),
Because posterior probability also increases in proportion
to the number and magnitude of various test abnormalities,
it thereby is an index of the anatomic extent of disease. This
inference could serve as an aid in the appropriate selection
of patients for coronary angiography.
Future coronary events. Because the angiographic se-
verity (that is, the magnitude and extent) of disease is an
important determinant of prognosis (37), it is also not sur-
prising that posterior probability correlated with the inci-
dence of both nonfatal myocardial infarction and cardiac
death in the year after testing. By using the empiric relation
between posterior probability and coronary events to predict
the number of events that were "lost" to follow-up in the
surgical patients and then adding these "events" to those
observed, the normalized morbid event rate for a medically
treated diseased population was predicted to be 3.1 ± 1.0%
in the year after testing, This value is consistent with recent
reports of similar groups of medically treated patients with-
out previous myocardial infarction (37-42). The almost equal
incidence of nonfatal infarction and cardiac death in our
study is in agreement with the observations of Harris et al.
(37), who followed up a similarly sized cohort over a longer
period of time.
When posterior probability was high (for example, >90%),
the probability of an event in the year after testing increased
substantially, but the standard deviation for this prediction
was large. This observation has an important implication
that is easily overlooked by clinicians. The data imply that
when noninvasive testing results in a low probability of
disease, we should be justifiably confident that such patients
have a good short-term prognosis. When posterior proba-
bility is greater than 90%, however, we should be very
unsure of a given patient's outlook. In this context, a state-
ment to the effect that a patient is at "high risk" can be
made with only a limited degree of confidence, and carries
an emotional impact out of proportion to our knowledge of
its accuracy and precision (5,43).
Clinical relevance of the study design. Several aspects
of our study design deserve emphasis. First, we sought to
determine the accuracy of probability analysis in an envi-
ronment that mirrored, as closely as possible, the realities
of clinical practice. Patients were excluded from entry into
this study, therefore, only if a diagnosis of coronary artery
disease was already absolutely established or excluded by
a documented prior myocardial infarction or coronary an-
giography. No attempt was made to influence the referring
physician in his choice of diagnostic tests or in his decision
to recommend coronary angiography or bypass surgery, be-
yond the customary communication that took place as part
of routine clinical care. Consequently, all tests were not
performed on all patients and the resultant data base was
unavoidably incomplete. Also, every test result we analyzed
was that which was formally reported to the referring phy-
sician. No separate "research readings" were performed.
Under these circumstances, the probability for disease av-
eraged 52% for all 1,097 patients referred for stress testing;
probability increased to 65% for the 170 patients referred
for angiography and to 90% for the 47 patients referred for
surgery. Whether or not this pattern of referral is represen-
tative of other laboratories (or is even appropriate) was not
addressed by our analysis. Lastly, the interpretation of each
test-from the history to the coronary angiogram-required
a variable amount of subjectivity. This, however, also mir-
rors clinical reality, and is in one sense desirable, because
the empiric data on which CADENZA is based were sim-
ilarly obtained (43).
In summary. a practical, readily available microcomputer
program that integrates a large base of published data has
been employed successfully in the diagnosis and evaluation
of coronary artery disease. Its continued development and
its current role as an aid to clinical management (44) appear
warranted.
APPENDIX
Bayes' Theorem
Ifwe have a complete system of n mutually exclusive states, 0 1,
O2 , ... On, then the probability of the ith state is denoted p(D.),
where L p(D,)= I. If any j of k independent observations, TJ'
1=1
is associated with each of these n states, then the conditional
probability of each of the k associations, denoted peT] I 0,), rep-
resents the probability that the observation TJ will occur given the
state 0,. The inverse probability, the conditional probability of 0,
given TJb is defined by Bayes' theorem:
p(D,) Ilp(T
Jk
I0,)
p(D, I T
Jk
) = __---"'Jk'--- _
L p(D,) Ilp(TJk I0,)
, jk
For the diagnosis of coronary artery disease, the set of 0, includes
only 0 + (disease)and 0 - (no disease). In this case, p(TJk I0 + )
is the sensitivity or true positive rate, and p(TJk I 0 - ) is the false
positive rate (I - specificity) of the kth observation, TJ • The In-
verse probability calculated by Bayes' Theorem, given the pnor
probability for disease, p(D+), and the set of k observations, TJ'
is p(D+ ITJk ) , the posterior probability for coronary artery disease.
Derivation of Input Probabilities
The discrete probabilities p(D+ ), P(T]k I0 +) and p(TJk I0 - )
were obtained directly from reported empiric observations (1-4):
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Number of individuals in a population, N, with characteristic J
p =
Total number of individuals in the population, N
In certain cases, these empiric probabilities were converted into
continuous variables (3) by regression analysis of a test charac-
teristic relative to a specific observation, j, such that p = F(j).
Table 5 summarizes these conversions.
r = p(D + ITJ) • n.
The symbol I' represents the gamma function:
[X (I ( I)Y-I
f(y) = Jo e- X xy- I dx = Jo In ~ dx.
Calculation of Variances
The variances of empiric probabilities were determined from the
equation:
(]'~ = pq/N = n(N - n)/N 3 ,
The uniform beta distribution defines the classic uninformative
Bayesian prior (14). Its parameters nand r may be derived by
recognizing that the restriction of uniformity requires that for all
values of p, B(n,r) = I, and its first derivative, B'(n,r) = 0:
[
r - I n - r - 11
-- - B(n,r) = 0,
p q
r-I n-r-
where N = total population, n = number of individuals in N with
the characteristic, j, p = n/N, and q = 1 - p = (N - nl/N.
The variances of continuous probabilites were calculated from the
first order terms of a Taylor series expansion of the function
F(j) = p such that:
B'(n.r) =
p q
= o.
(]'~= (:r·(]';.
When those independent and uncorrelated errors are introduced
into Bayes' equation for calculation of p(D + ITJ) , the resultant
posterior variance «(]'2) is given by a partial differential equation
which sums the individual errors in quadrature:
(]'2 = G~r .(]'~ + G~r .(]'~ + G~r .(]'~,
where L = p(D+ ITJ) , A = p(TJ ID+), B = p(TJ ID-),
P = p(D +). We evaluate the partial derivatives by substitution
into Bayes' equation:
When p = 0, then q = I and r - I = O. When p = I, then
q = 0 and - n + r + I = O. Thus, r = I and n = 2.
The uniform prior distribution is therefore defined by the spe-
cific beta distribution, B(2, I), with mean p = rln = 1/2 and
variance (]'2 = pq/n = 118. The parameters of a posterior beta
distribution which derive from the uniform prior are n = 1/2pq
and r = 1/2q. These parameters were employed in calculating the
test statistic, t/J (see Appendix, The Exact Posterior Probability).
If one has two sets of N, postenor probabilities, p(D + ITJ) and
their individual associated variances, (]'~, for each of two exhaus-
tive states, D" we can define the mean posterior probability of
each set as:
The variance of this mean is denoted (]'~, , and the average variance
of the individual probabilities is:
-2 _ ~ 2
a PI - .LJN
1
U PN, IN 1
We can then express each set as a beta distribution, B(n"r,), and
define a new function that represents the normalized probability
(or prevalence) of the state D + , given a specific observed posterior
probability:
P(D+ Ip(D+ IT
J
») = B(n"rl) = F(P).
B(n),rl) + B(n2,r2)
p(T
J
ID+) ,
II p(D, ITJ),
p(T
J
I D-) ,
IIp(D, IT,)
aL
aB
aL
aA
aL
ap II, p(D,) ,
~ p(D, ITJ) • [ C(T
J
I~+ ») 2
+ (P(TJI~-)r + (II :~D,)r1
Beta Frequency Distribution
The beta function is defined by:
fen)B(n,r) = . pll-II . q'": I-II.
fer) I'(n - r)
This function describes the frequency distribution of a continuous
variable, such as posterior probability, which varies from 0 to I
in terms of two parameters, nand r:
This function has a variance defined by:
(]'2F(P) = [F'(P)]2 . a~,
where F'(P) is the first derivative of F(P):
F(P) = [r2 - rl _ nl - rl - n2 + r21P I _ P . F(P)' [I - F(P)1
and a~ is the total variance of P:
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The Exact Posterior Probability
When disease probability IS expressed as a density function such
as B(n,r), its information content (45) is defined by the entropy
of each possible value of posterior probability weighted for Its
beta distributed frequency of occurrence (46). We thereby define
the entropy distribution S(n,r) as:
S(n,r) = - B(n,r) L p(DI ITJ)log2 p(DI ITJ) .
This function evaluates to zero at the extremes of posterior prob-
ability, and increases to a single maximum at some 0 < 1/1 < I
which satisfies the condition that the denvative of the entropy
function is zero:
S'(n.r) = 0 = [(n - r) - I ~ 1/1 ( r - I)JIn (I - 1/1)
- [r - _1/1_ (n - r- 1)1 In 1/1.
1-1/1
This "exact" posterior probability is uniquely defined by the mean
and standard deviation of the posterior probability distribution
which define the parameters nand r. It is almost identical to the
median of the distribution and represents the maximal informa-
tional probability for a given patient (43). In physics, entropy is
the sole determinant of thermodynamic equilibrium at constant
energy (47). It is convenient, therefore, to view the exact posterior
probability, 1/1, as the informational "equilibrium" of the posterior
probability distribution. The exact posterior probability, therefore,
may be employed as a meaningful summary statistic of the entire
posterior probability distribution. When 1/1 is calculated from a
likelihood estimator such as K (13), it represents the posterior
probability of the hypothesis complementary to the null hypothesis
(see Methods). This statistic, therefore, is more relevant to hy-
pothesis testing than the conventional p value which is equivalent
to a false positive rate (48-50).
We wish to express our gratitude to Patncia Allen for editonal assistance,
to Lance Laforteza and Rosa Goldsmith for graphics, to Joye Nunn for
secretarial services and to Patncia Edwards for photography.
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